Eventide Asset Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$2.16M Sell
2022
Q4
$2.92M Sell
2022
Q3
$4.09M Hold
2022
Q2
$5.17M Buy
2022
Q1
$3.97M Buy
2021
Q4
$6.75M Hold
2021
Q3
$11.8M Buy
2021
Q2
$19.8M Hold
2021
Q1
$29.8M Hold
2020
Q4
$44.3M Buy
2020
Q3
$35.6M Buy